| Date | Time | Source | Headline | Symbol | Company |
| 14/02/2019 | 21:00 | Edgar (US Regulatory) | Amended Statement of Ownership (sc 13g/a) | NASDAQ:IPXL | Impax Laboratories, Inc. (delisted) |
| 12/02/2019 | 14:47 | Edgar (US Regulatory) | Schedule 13g | NASDAQ:IPXL | Impax Laboratories, Inc. (delisted) |
| 07/06/2018 | 21:35 | Edgar (US Regulatory) | Amended Tender Offer Statement by Issuer (sc To-i/a) | NASDAQ:IPXL | Impax Laboratories, Inc. (delisted) |
| 10/05/2018 | 21:20 | Edgar (US Regulatory) | Quarterly Report (10-q) | NASDAQ:IPXL | Impax Laboratories, Inc. (delisted) |
| 08/05/2018 | 21:39 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:IPXL | Impax Laboratories, Inc. (delisted) |
| 08/05/2018 | 21:36 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:IPXL | Impax Laboratories, Inc. (delisted) |
| 08/05/2018 | 21:35 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:IPXL | Impax Laboratories, Inc. (delisted) |
| 08/05/2018 | 21:34 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:IPXL | Impax Laboratories, Inc. (delisted) |
| 08/05/2018 | 21:34 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:IPXL | Impax Laboratories, Inc. (delisted) |
| 08/05/2018 | 21:28 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:IPXL | Impax Laboratories, Inc. (delisted) |
| 08/05/2018 | 21:28 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:IPXL | Impax Laboratories, Inc. (delisted) |
| 08/05/2018 | 21:26 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:IPXL | Impax Laboratories, Inc. (delisted) |
| 08/05/2018 | 21:23 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:IPXL | Impax Laboratories, Inc. (delisted) |
| 08/05/2018 | 21:22 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:IPXL | Impax Laboratories, Inc. (delisted) |
| 08/05/2018 | 21:21 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:IPXL | Impax Laboratories, Inc. (delisted) |
| 08/05/2018 | 21:13 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:IPXL | Impax Laboratories, Inc. (delisted) |
| 08/05/2018 | 21:11 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:IPXL | Impax Laboratories, Inc. (delisted) |
| 07/05/2018 | 14:11 | Edgar (US Regulatory) | Tender Offer Statement by Issuer (sc To-i) | NASDAQ:IPXL | Impax Laboratories, Inc. (delisted) |
| 07/05/2018 | 13:30 | PR Newswire (US) | ANI Pharmaceuticals Completes Acquisition of Generic Products and Assets from Amneal/Impax | NASDAQ:IPXL | Impax Laboratories, Inc. (delisted) |
| 07/05/2018 | 13:28 | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:IPXL | Impax Laboratories, Inc. (delisted) |
| 07/05/2018 | 11:00 | PR Newswire (US) | Amneal and Impax Complete Business Combination | NASDAQ:IPXL | Impax Laboratories, Inc. (delisted) |
| 04/05/2018 | 22:05 | Edgar (US Regulatory) | (25-NSE) | NASDAQ:IPXL | Impax Laboratories, Inc. (delisted) |
| 02/05/2018 | 23:19 | PR Newswire (US) | Apergy Set to Join S&P MidCap 400; 3D Systems to Join S&P SmallCap 600 | NASDAQ:IPXL | Impax Laboratories, Inc. (delisted) |
| 30/04/2018 | 11:20 | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:IPXL | Impax Laboratories, Inc. (delisted) |
| 27/04/2018 | 23:50 | PR Newswire (US) | Amneal And Impax Receive FTC Clearance For Business Combination | NASDAQ:IPXL | Impax Laboratories, Inc. (delisted) |
| 27/04/2018 | 23:30 | PR Newswire (US) | ANI Pharmaceuticals Signs Definitive Agreements to Acquire Generic Products and Assets from Amneal/Impax | NASDAQ:IPXL | Impax Laboratories, Inc. (delisted) |
| 13/04/2018 | 22:04 | Edgar (US Regulatory) | Amended Annual Report (10-k/a) | NASDAQ:IPXL | Impax Laboratories, Inc. (delisted) |
| 10/04/2018 | 18:59 | Edgar (US Regulatory) | Amended Statement of Ownership (sc 13g/a) | NASDAQ:IPXL | Impax Laboratories, Inc. (delisted) |
| 06/04/2018 | 12:33 | PR Newswire (US) | Impax Launches a Generic Version of Estrace® Cream (estradiol vaginal cream, USP, 0.01%) | NASDAQ:IPXL | Impax Laboratories, Inc. (delisted) |
| 05/04/2018 | 22:24 | Edgar (US Regulatory) | Confidential Treatment Order (ct Order) | NASDAQ:IPXL | Impax Laboratories, Inc. (delisted) |